Author

Satoshi Tanida 1

1 Nagoya City University Graduate School of Medical Sciences,Nagoya,Japan

EFFICACY OF UPADACITINIB AS AN INDUCTION THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS, WITH OR WITHOUT PREVIOUS TREATMENT FAILURE OF BIOLOGIC THERAPY: DATA FROM THE DOSE-RANGING PHASE 2B STUDY U-ACHIEVE

Remo Panaccione, Geert R. D'Haens, William Sandborn, Subrata Ghosh, Stefan Schreiber, Satoshi Tanida, Wen Zhou, Fabio Cataldi, David Pugatch, Bidan Huang, Wangang Xie, Peter Higgins

EFFICACY OF UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS BY BIOLOGIC INADEQUATE RESPONDER STATUS: RESULTS FROM TWO RANDOMIZED PHASE 3 STUDIES

Severine Vermeire, Hu Renwei, Remo Panaccione, Satoshi Tanida, Xavier Hebuterne, Ilo Dapo, Zhou Wen, Zhou Qing, Silvio Danese, Michael Weinreich, David T. Rubin

Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in elderly patients with inflammatory bowel disease: A multicentre cohort study

Hiroki Tanaka, Masanao Nasuno, Tomoyoshi Shibuya, Taro Osada, Ayumi Ito, Toshihisa Kobayashi, Reiko Kunisaki, Hitoshi Hongo, Satoshi Tanida, Eiji Hosoi

Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in paediatric patients with inflammatory bowel disease: a multicentre cohort study

Nariaki Toita, Hiroki Tanaka, Katsuhiro Arai, Hirotaka Shimizu, Daiki Abukawa, Toshihisa Kobayashi, Naoki Yoshimura, Satoshi Tanida, Eiji Hosoi

SYMPTOMS AND LABORATORY VALUES AS PROXIES FOR ENDOSCOPIC AND HISTOLOGIC CLINICAL ENDPOINTS IN ULCERATIVE COLITIS: A MEDIATION ANALYSIS BASED ON UPADACITINIB PHASE 3 INDUCTION TRIALS

Marla C. Dubinsky, MIn A. Yang, Mirko Fillbrunn, Silvio Danese, Johan Burisch, Satoshi Tanida, Dolly Sharma, Dapo Ilo, Wen Zhou, Yuri Sanchez Gonzalez, Laurent Peyrin-Biroulet

Item 1 - 5 / 5
1